В Сингапуре приостановлены продажи популярного корейского крема Medicube из-за подозрений в наличии запрещенного красителя

The Health Sciences Authority (HSA) is investigating the Medicube PDRN Pink Collagen Capsule Cream, following reports that it may contain a prohibited ingredient. HSA is working with three companies marketing the product to suspend sales and recall the product while investigations are underway. The product first came under the spotlight on July 24, when Hong Kong Customs warned members of the public against using the cream and appealed to merchants to remove it from their shelves. The cream is suspected of containing the prohibited Sudan Red dye, according to Hong Kong Customs. Sudan Red dyes have been linked to potential carcinogenic and allergenic effects. Medicube has emerged as one of South Korea's most recognisable skincare brands in recent years, gaining a strong international following through social media platforms. The Medicube PDRN Pink Collagen Capsule Cream is one of the brand's most viral products. Marketed as containing PDRN, an ingredient derived from salmon DNA, and collagen, the cream is widely available on e-commerce platforms and has built a substantial following among K-beauty fans worldwide. HSA Investigations In response to AsiaOne's queries, HSA said it was aware of recent reports regarding the South Korean product. The agency has commenced investigations and will be testing the product. HSA said it will take relevant regulatory action should safety concerns be detected. "In the meantime, consumers who have purchased the products should stop using them as a precautionary measure," HSA said. Sudan Red dyes are not allowed in cosmetic products sold locally as they are prohibited under the Health Products (Cosmetic Products — Asean Cosmetic Directive) Regulations 2007. HSA said dealers must notify the agency before any cosmetic products can be placed on the market. The notification facilitates regulatory follow-up if safety concerns arise. However, HSA stressed that product notification is not a form of pre-market approval and should not be construed as product certification or registration by the agency. The agency also reminded dealers to ensure that their cosmetic products comply with regulatory requirements, including restrictions on the use of certain ingredients, the reporting of serious adverse effects to HSA and product labelling requirements. HSA noted that any person found to have supplied products containing prohibited Sudan Red dyes may face a fine of up to S$50,000 and/or an imprisonment term of up to two years. [[nid:741125]]